InvestorsHub Logo
Followers 220
Posts 1626
Boards Moderated 0
Alias Born 01/05/2005

Re: htrade post# 38325

Saturday, 05/05/2012 11:05:00 PM

Saturday, May 05, 2012 11:05:00 PM

Post# of 75926
HTRADE I've posted about CEO's daughter before read...

highflier Sunday, April 01, 2012 3:16:11 PM
Re: None Post # of 38326


Key points taken from the Annual Report...

The Company must comply with FDA and European CE Mark requirements for its products in order to sell its products in theses respective markets. The Company has complied with FDA requirements on all of its products where FDA approval is required for its products currently marketed in the US. This will disspell any doubt about all their product being FDA approved.

The Company markets its products to hospitals, surgery centers and physician offices. That is a really big market.

The Company believes the nature of the Solos’ products will allow it to be used with complementary products and technologies in both the breast and ENT endoscopy markets. And as such, the Company will look to form key partnerships with leading endoscopy technology companies. This will be a huge plus to SNDY because it will get them much more exposure in the market place.

The President, Treasurer and Director of the Company, Robert Segersten is the father of the Secretary of the Company, Amanda Segersten. I have to believe, as a father, we always want to take care of our daughters. Amamnda has been with the company for 12 years. I'm sure Robert wants to see the hard work she has put in finally pay off for her. She gave up her common stock as well for preferred B stock options. I'm sure her dad is not going to put her into a position to loose money, but to make the payoff in the end very rewarding.

Sometimes it is the little things that makes it clearer to see the big picture. It is certainly the case for me with SNDY.



Take care my friends,
Mike